MTD
Price
$1738.91Alerts
Change
+$7.98 (+0.46%)
Updated
Nov 13 closing price
Capitalization
34.51B
89 days until earnings call
Intraday BUY SELL Signals
SHC
Price
$16.61Alerts
Change
+$0.31 (+1.90%)
Updated
Nov 13 closing price
Capitalization
4.57B
108 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MTD vs SHC

MTD vs SHC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MTD vs. SHC commentary
Nov 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a Hold and SHC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MTD with price predictions
Nov 13, 2026

MTD in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 09, 2026

MTD broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 36 of the 42 cases the stock fell afterwards. This puts the odds of success at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MTD moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 22 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 63 cases where MTD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for MTD turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 30 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MTD as a result. In 61 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

Following a +4.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTD advanced for three days, in 192 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 132 of 226 cases where MTD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 5 (best 1 - 100 worst), indicating outstanding price growth. MTD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MTD's P/B Ratio (2690.943) is very high in comparison to the industry average of (67.298). P/E Ratio (38.717) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (2.869) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (6.798) is also within normal values, averaging (9.775).

A.I.Advisor
a Summary for SHC with price predictions
Nov 13, 2026

SHC's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for SHC moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 25 of the 37 cases the stock moved higher. This puts the odds of a move higher at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where SHC advanced for three days, in 186 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

SHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SHC as a result. In 55 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for SHC turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

SHC moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

The Aroon Indicator for SHC entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. SHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.864) is normal, around the industry mean (67.298). P/E Ratio (28.088) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.313) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (4.587) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

FUNDAMENTALS RATINGS
MTD vs SHC: Fundamental Ratings
MTD
SHC
OUTLOOK RATING
1..100
3417
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
335
PRICE GROWTH RATING
1..100
560
P/E GROWTH RATING
1..100
3494
SEASONALITY SCORE
1..100
n/a18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHC's Valuation (74) in the null industry is in the same range as MTD (99) in the Medical Specialties industry. This means that SHC’s stock grew similarly to MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (70) in the Medical Specialties industry is in the same range as SHC (100) in the null industry. This means that MTD’s stock grew similarly to SHC’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is in the same range as SHC (35) in the null industry. This means that MTD’s stock grew similarly to SHC’s over the last 12 months.

MTD's Price Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for SHC (60) in the null industry. This means that MTD’s stock grew somewhat faster than SHC’s over the last 12 months.

MTD's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for SHC (94) in the null industry. This means that MTD’s stock grew somewhat faster than SHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTDSHC
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
62%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 12 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
80%
COMPARISON
Comparison
Nov 15, 2026
Stock price -- (MTD: $1738.91 vs. SHC: $16.61)
Brand notoriety: MTD and SHC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MTD: 69% vs. SHC: 122%
Market capitalization -- MTD: $34.51B vs. SHC: $4.57B
MTD [@Medical Specialties] is valued at $34.51B. SHC’s [@Medical Specialties] market capitalization is $4.57B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTD’s FA Score shows that 2 FA rating(s) are green while SHC’s FA Score has 0 green FA rating(s).

  • MTD’s FA Score: 2 green, 3 red.
  • SHC’s FA Score: 0 green, 5 red.
According to our system of comparison, MTD is a better buy in the long-term than SHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTD’s TA Score shows that 3 TA indicator(s) are bullish while SHC’s TA Score has 4 bullish TA indicator(s).

  • MTD’s TA Score: 3 bullish, 5 bearish.
  • SHC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SHC is a better buy in the short-term than MTD.

Price Growth

MTD (@Medical Specialties) experienced а +0.97% price change this week, while SHC (@Medical Specialties) price change was +3.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.79%. For the same industry, the average monthly price growth was -7.29%, and the average quarterly price growth was +34.42%.

Reported Earning Dates

MTD is expected to report earnings on Feb 11, 2027.

SHC is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Medical Specialties (-1.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+0.46%
A - MTD
69%
Closely correlated
+0.55%
BRKR - MTD
67%
Closely correlated
+2.09%
TMO - MTD
63%
Loosely correlated
+0.11%
AZTA - MTD
61%
Loosely correlated
+4.08%
RGEN - MTD
58%
Loosely correlated
+0.76%
More

SHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHC has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SHC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHC
1D Price
Change %
SHC100%
+1.90%
RVTY - SHC
53%
Loosely correlated
-1.67%
CRL - SHC
52%
Loosely correlated
-0.83%
MTD - SHC
49%
Loosely correlated
+0.46%
TMO - SHC
48%
Loosely correlated
+0.11%
DHR - SHC
47%
Loosely correlated
+0.37%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AGGM99.99-0.05
-0.05%
iShares 1-10 Year U.S. Aggregate Bond ETF (AGGM)
BCSM24.83-0.05
-0.18%
Baron SMID Cap ETF (BCSM)
CWI39.29-0.11
-0.28%
State Street SPDR MSCI ACWI ex-US ETF (CWI)
SMYY5.03-0.10
-2.03%
GraniteShares YieldBOOST SMCI ETF (SMYY)
JRI11.29-0.27
-2.34%
NUVEEN REAL ASSET Income AND GROWTH FUND